JRF-107

N/A

Report date: 2023/10/17 16:47:29
NME

Base Information

Drug NameJRF-107
Drug Alias NameJRF-107
ClassificationOther
Mechanisms of ActionNuclear receptor ROR-gamma inverse agonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShenzhen Jinrui Foundation Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Jinrui Foundation Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A